Xtant Medical Inc.

AMEX: XTNT · Real-Time Price · USD
0.63
-0.02 (-3.08%)
At close: Jun 13, 2025, 3:51 PM
0.62
-1.69%
After-hours: Jun 13, 2025, 04:00 PM EDT

Xtant Medical Statistics

Share Statistics

Xtant Medical has 139.32M shares outstanding. The number of shares has increased by 6.75% in one year.

139.32M
6.75%
0.04%
71.57%
115.47M
4,271
2.27%

Short Selling Information

The latest short interest is 24.19K, so 0.02% of the outstanding shares have been sold short.

24.19K
0.02%
0.06%
1

Valuation Ratios

The PE ratio is -3.6 and the forward PE ratio is -32.5. Xtant Medical's PEG ratio is 0.

-3.6
-32.5
0.5
0.6
1.38
-3.7
0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Xtant Medical.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 2.35, with a Debt / Equity ratio of 0.82.

2.35
1
0.82
-4.46
-2.2
-2.9

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$540,400.92
$-75,801.84
217
1.25
1.27

Taxes

187K
-1.15%

Stock Price Statistics

The stock price has increased by -16.11% in the last 52 weeks. The beta is -0.17, so Xtant Medical's price volatility has been lower than the market average.

-0.17
-16.11%
0.56
0.53
46.72
188,436

Income Statement

In the last 12 months, Xtant Medical had revenue of 117.27M and earned -16.45M in profits. Earnings per share was -0.12.

117.27M
68.22M
-12.07M
-16.45M
-7.88M
-12.1M
-0.12
Full Income Statement

Balance Sheet

The company has 6.2M in cash and 35.14M in debt, giving a net cash position of -28.94M.

6.2M
35.14M
-28.94M
-259.46M
95.83M
39.56M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -11.9M and capital expenditures -4.11M, giving a free cash flow of -16.01M.

-11.9M
-4.11M
-16.01M
-0.12
Full Cash Flow Statement

Margins

Gross margin is 58.17%, with operating and profit margins of -10.3% and -14.03%.

58.17%
-10.3%
-13.87%
-14.03%
-6.72%
-10.3%
-13.65%

Dividends & Yields

XTNT does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for XTNT is $3, which is 376.2% higher than the current price. The consensus rating is "Strong Buy".

$3
376.2%
Strong Buy
1
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Feb 14, 2018. It was a backward split with a ratio of 1:12.

Feb 14, 2018
backward
1:12

Scores

-1.15
3